ПАТОГЕНЕТИЧЕСКИЕ МЕХАНИЗМЫ ДЕЙСТВИЯ СТРУКТУРНО-МОДИФИЦИРУЮЩИХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ ЗАМЕДЛЕННОГО ДЕЙСТВИЯ (SYSADOA)
2017
The article is devoted to the combined indication of chondroitin drugs – Arthradol and glucosamine – ArthraCam in therapy of ostheoorthrosis. A symptom-modifying effect in monotherapy and in course therapy by Arthradol and ArthroCam on the background of non-steroid anti-inflammatory drugs.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI